Abstract
Thin-layer chromatography (TLC) is a nonquantitative technique, which has been employed in the detection of antiphospholipid (aPL) antibodies. Antiphospholipid syndrome (APS) is the most frequently acquired thrombophilia, characterized by thrombosis and obstetric manifestations associated to an autoimmune trait, represented by the positivity of antiphospholipid (aPL) antibodies. Immunoassays for anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) antibodies and clotting tests for lupus anticoagulant (LA) represent the standard tests for the routine detection of aPL. The term “seronegative APS” has been used to describe patients with clinical manifestation of APS and persistently negative aPL assessed with routine assays. TLC immunostaining is a useful method for the detection of different antigenic targets of “antiphospholipid” antibodies; it is able to identify the reactivity of serum aPL experimented with purified phospholipid molecules with a different exposure compared to ELISA methods. This method seems to be applicable in patients who repeatedly tested negative for the standard aPL, i.e., aCL, aβ2GPI, and LA. Therefore, this technique may be proposed as a second step test for the diagnosis of APS.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li JL, Matsuda K, Takagi M, Yamamoto N (1997) Detection of serum antibodies against phosphocholine-containing aminoglycoglycerolipids specific to Mycoplasma fermentans in HIV-1 infected individuals. J Immunol Methods 208:103–113
Sorice M, Griggi T, Circella A, Garofalo T, d’Agostino F F, Pittoni V et al (1994) Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods 173:49–54
Hughes GR (1985) The anticardiolipin syndrome. Clin Exp Rheumatol 3:285–286
Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G (2004) Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 6:R366–R372
Valesini G, Alessandri C, Celestino D, Conti F (2006) Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus. Ann N Y Acad Sci 1069:118–128
Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M et al (2012) T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 26:4722–4732
Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C et al (2012) Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 64:778–787
Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F et al (2012) Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS ONE 7(3):e33824
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Hughes GR, Khamashta M (2003) Seronegative antiphospholipid syndrome. Ann Rheum Dis 62:1127
Rodriguez-Garcia JL, Bertolaccini ML, Cuadrado MJ, Sanna G, Ateka-Barrutia O, Khamashta MA (2012) Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called “seronegative APS”). Ann Rheum Dis 71:242–244
Sorice M, Ferro D, Misasi R, Pittoni V, Longo A, Circella A et al (2002) Evidence for anticoagulant activity and β2-GPI accumulation in late endosomes of endothelial cells induced by anti-LBPA antibodies. Thromb Haemost 87:735–741
Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G et al (2005) Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol 140:173–180
Oku K, Atsumi T, Amengual O, Koike T (2008) Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Haemost 34:335–339
Sanmarco M et al (2007) Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost 97:949–954
Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A et al (2010) Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood 116:2960–2967
Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T et al (2012) Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol 167:429–437
Sorice M, Circella A, Griggi T, Garofalo T, Nicodemo G, Pittoni V et al (1996) Anticardiolipin and anti-β2GPI are two distinct populations of autoantibodies. Thromb Haemost 75:303–308
Sorice M, Pittoni V, Griggi T, Losardo A, Leri O, Magno MS et al (2000) Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol 120:301–306
Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T et al (2006) Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res Ther 8:R180–R190
Capozzi A, Lococo E, Grasso M, Longo A, Garofalo T, Misasi R, Sorice M (2012) Detection of antiphospholipid antibodies by automated chemiluminescence assay. J Immunol Methods 379:48–52
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Conti, F. et al. (2014). TLC Immunostaining for Detection of “Antiphospholipid” Antibodies. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols